Statement Of Financial Position [Abstract]

Xspray Pharma - Filing #702829

Concept	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31
Statement of financial position [abstract]
Assets [abstract]
Non-current assets [abstract]
Property, plant and equipment	44 601 SEK	—	—	—	—	42 669 SEK	—	—	—	—	—	—	—	—	—
Right-of-use assets	3 526 SEK	—	—	—	—	5 207 SEK	—	—	—	—	—	—	—	—	—
Non-current assets	340 838 SEK	—	—	—	—	274 288 SEK	—	—	—	—	—	—	—	—	—
Current assets [abstract]
Current inventories	6 199 SEK	—	—	—	—	- SEK	—	—	—	—	—	—	—	—	—
Trade and other current receivables	2 473 SEK	—	—	—	—	2 667 SEK	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	271 881 SEK	—	—	—	—	325 598 SEK	—	—	—	—	—	—	209 872 SEK	—	—
Current assets	282 065 SEK	—	—	—	—	331 015 SEK	—	—	—	—	—	—	—	—	—
Assets	622 903 SEK	—	—	—	—	605 303 SEK	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	20 680 SEK	—	—	—	—	18 893 SEK	—	—	—	—	—	—	—	—	—
Retained earnings	243 387 SEK	—	—	—	—	146 689 SEK	—	—	—	—	—	—	—	—	—
Other reserves	976,000 SEK	—	—	—	—	976,000 SEK	—	—	—	—	—	—	—	—	—
Equity attributable to owners of parent	591 752 SEK	—	—	—	—	582 587 SEK	—	—	—	—	—	—	—	—	—
Equity	591 752 SEK	243 387 SEK	976,000 SEK	813 483 SEK	20 680 SEK	582 587 SEK	18 893 SEK	146 689 SEK	709 407 SEK	976,000 SEK	94 279 SEK	976,000 SEK	373 715 SEK	450 266 SEK	16 752 SEK
Liabilities [abstract]
Non-current liabilities [abstract]
Non-current liabilities	1 185 SEK	—	—	—	—	2 898 SEK	—	—	—	—	—	—	—	—	—
Current liabilities [abstract]
Current liabilities	29 966 SEK	—	—	—	—	19 818 SEK	—	—	—	—	—	—	—	—	—
Equity and liabilities	622 903 SEK	—	—	—	—	605 303 SEK	—	—	—	—	—	—	—	—	—